Welcome to Erbitux International.com
This is an international educational resource, provided by Merck KGaA, Darmstadt, Germany, for healthcare professionals interested in cancer and Erbitux® (cetuximab).
Erbitux is a trademark of Imclone Systems Incorporated, a wholly-owned subsidiary of Eli Lilly and Company, licensed to Merck KGaA, Darmstadt, Germany.


